Two investment firms have acquired large stakes in global CRO Novotech, the Singapore-based company announced March 30. GIC ...

Novotech, a globally recognized full-service biotech specialist clinical research organization (CRO), announced today that ...

With a global footprint that includes 30+ offices across the Asia-Pacific region, North America, and Europe and partnerships with 5,000+ trial sites, Novotech provides clients an accelerated path to ...

Novotech provides biotech to small and mid-sized pharma companies. GIC and Temasek have signed a binding agreement to acquire ...

The two sovereign wealth funds have taken a “significant stake” in the clinical research business owned by the private equity ...

Temasek Holdings Pte and GIC Pte Ltd. will acquire a significant stake in Novotech Pty Ltd. to fuel growth and accelerate ...

SINGAPORE] Clinical research and testing provider Novotech on Monday (Mar 31) announced that Temasek and GIC will acquire a ...

Since TPG’s investment in 2017, the firm has raised its headcount tenfold to 3,000 employees and expanded its operations ...

SYDNEY--(BUSINESS WIRE)--Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company that provides biotech and small- to mid-sized pharma ...

Novotech, a globally recognized full-service biotech specialist clinical research organization (CRO), announced today that affiliates of GIC and Temasek have signed binding agreements to acquire a ...

Temasek and GIC will acquire a significant stake in Novotech, whose ebitda has grown fivefold since TPG’s initial investment ...